Re-screening of negative smears in uterine cervical cancer mass screening-Reference-Cited by-同舟云学术

Re-screening of negative smears in uterine cervical cancer mass screening

Published:2018 Issue:1 Volume:57 Page:1-6
ISSN:0387-1193
Container-title:The Journal of the Japanese Society of Clinical Cytology
language:en
Short-container-title:J. Jpn. Soc. Clin. Cytol

Author:

MORIMURA Yutaka¹²,TORAIWA Ryoko¹,NOGUCHI Maki¹,SATOH Nami¹,SATOH Mikako¹,KAMIO Junko¹,NOMURA Shinji³,SOEDA Shu³,WATANABE Takafumi³,FUJIMORI Keiya³

Affiliation:

1. Fukushima Preservation Service Association of Health

2. Department of Gynecology, Hanyu General Hospital

3. Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine

Publisher

The Japanese Society of Clinical Cytology

Link

https://www.jstage.jst.go.jp/article/jjscc/57/1/57_1/_pdf

Reference15 articles.

1. 1) Wood, R. J., Hicklin, M. D. Rescreening as a quality control procedure in cytopathology. Acta Cytol 1977 ; 21 : 240-246.

2. 2) US Department of Health and Human Services. Clinical laboratory improvement amendments of 1988. Final rule. Federal register 1992 ; 57 : 7001-7186.

3. 3) From the centers for disease control regulations for implementing clinical laboratory improvement Amendments of 1988 : A Summary. JAMA 1992 ; 267 : 1725-1734.

4. 6) Jones, B. A. Rescreening in gynecological cytology. Rescreening of 8096 previous cases for current low-grade and indeterminate-squamous intraepithelial lesion diagnoses. ―a College of American Pathologists Q-Probes study of 323 laboratories. Arch Pathol Lab Med 1996 ; 20 : 519-522.

5. 7) Johnson, S. J., Hair, T., Gibson, L., Ridley, B., Wadehra, V. An assessment of partial rescreening as an internal quality control method for cervical smears. Cytopathol 1995 ; 6 : 376-387.